Speaker illustration

Doctor Tarek Nafee

Harvard Medical School, Boston (United States of America)

Identification of atrial fibrillation patients who are at high bleeding risk after undergoing percutaneous coronary intervention: insights from the PIONEER AF-PCI trial

Event: ESC Congress 2018

Topic: Oral Anticoagulation

Session: Atrial fibrillation - Anticoagulation

Thumbnail

Performance of a machine learning model vs. IMPROVE score for VTE prediction in acute medically ill patients: insights from the APEX trial

Event: ESC Congress 2018

Topic: Scores

Session: Young Investigator Award Session Thrombosis

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb